CAI
Caris Life Sciences, Inc.Company with tickers: CAI
CIK
2019410
CUSIP
142152107
Shares Outstanding
282,680,695
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $120,915,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $23,066,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-57,952,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-102,581,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-3.57 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-3.57 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |